Track insider transactions across markets
| 30 days | 90 days | 120 days | |
|---|---|---|---|
| Average return | 1% | 8.2% | 15.1% |
| Success rate | 61% | 68% | 82% |
| Transactions |
15
0% Buy
|
34
71% Buy
|
47
69% Buy
|
| Position | Company | Period |
|---|---|---|
| Chief Operating Officer, Chief Scientific Officer | Catalyst Pharmaceuticals Inc | Jan. 21, 2011 - |
Search